Nature: Lyopitized powder
Color: White Freeze-Dried Powder
Material: Powder
Function: Sliming
Minimum order size: 1 box
Payment terms: Paypal, Bank Transfer, Western Union, USD T, BTC
Supply capacity: 500000 Boxes/week
Delivery term: Wishin 24 hours
Regular packing: 10/box
Kategoriler:GLP-1 TR
Tirzepatide mechanism of action: effects on endocrine function and insulin resistance in patients with type 2 diabetes. Tirzepatide is a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 (GLP-1) receptor agonist approved in the United States as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. It is under investigation for use in chronic weight management, major adverse cardiovascular events, and the management of other conditions, including heart failure with preserved ejection fraction, obesity, and non-cirrhotic non-alcoholic steatohepatitis. The Phase 3 SURPASS 1-5 clinical trial programme was designed to assess the efficacy and safety of once-weekly subcutaneously injected tirzepatide (5, 10, and 15 mg), as monotherapy or combination therapy, across a broad spectrum of people with type 2 diabetes.
Use of tirzepatide in clinical studies was associated with marked reductions in glycated haemoglobin (-1.87 to -2.59%, -20 to -28 mmol/mol) and body weight (-6.2 to -12.9 kg), as well as reductions in parameters commonly associated with heightened cardiometabolic risk such as blood pressure, visceral adiposity, and circulating triglycerides. In SURPASS-2, these reductions were greater than those with the GLP-1 receptor agonist se1 mg. Tirzepatide was well tolerated, with a low risk of hypoglycaemia when used without insulin or insulin secretagogues, and showed a generally similar safety profile to the GLP-1 receptor agonist class. Accordingly, evidence from these clinical trials suggests that tirzepatide offers a new opportunity for the effective lowering of glycated haemoglobin and body weight in adults with type 2 diabetes.
Şirket sloganı: Yenilik, İşbirliği, Kazan-Kazan
Şirket Tanıtımı: Zhengzhou Longjia Elektronik Teknoloji Şirketi, Ltd., peptitler, ilaç hammaddeleri, ilaç araları ve ince kimyasal ara maddelerin araştırma ve geliştirme, üretimi ve satışına adanmış profesyonel bir ilaç teknoloji şirketidir.
Şirket ekibi: Zhengzhou Longjia Electronic Technology Co., Ltd. has a strong technical background, and the team members are all doctoral, master's, and undergraduate students. They are skilled in process route design, synthesis, process optimization, and new drug research for drugs and chemical intermediates. At the same time, the company is equipped with various advanced HPLC-MS, GC-MS instruments and organic synthesis detection equipment, which can meet the detection needs from milligrams to kilograms.
Şirket sloganı: Yenilik, İşbirliği, Kazan-Kazan
Şirket Tanıtımı: Zhengzhou Longjia Elektronik Teknoloji Şirketi, Ltd., peptitler, ilaç hammaddeleri, ilaç araları ve ince kimyasal ara maddelerin araştırma ve geliştirme, üretimi ve satışına adanmış profesyonel bir ilaç teknoloji şirketidir.
Şirket ekibi: Zhengzhou Longjia Electronic Technology Co., Ltd. has a strong technical background, and the team members are all doctoral, master's, and undergraduate students. They are skilled in process route design, synthesis, process optimization, and new drug research for drugs and chemical intermediates. At the same time, the company is equipped with various advanced HPLC-MS, GC-MS instruments and organic synthesis detection equipment, which can meet the detection needs from milligrams to kilograms.
In the future, the company will continue to be committed to "doing fine, specialized and stronger", and strive to build an advanced professional manufacturing base in the industry.
Telif Hakkı © 2024 Zhengzhou Longjia Electronic Technology Co., Ltd. Tüm Hakları Saklıdır.Gizlilik Politikası
